Literature DB >> 13009500

Primary neoplasms of the adrenal gland; diagnosis and surgical management.

H A DAVIS, I A FIELDS, A GERBER.   

Abstract

Tumors of the adrenal glands produce hormones which cause a variety of symptoms and signs including high blood pressure, excessive growth of hair on the body and precocious sexual development. By recently developed tests, it has been possible to differentiate high blood pressure due to these tumors from hypertension due to other causes. Removal of these tumors will often alleviate changes caused by them. Localization of the tumor and appraisal of the condition of the contralateral gland should be carried out preoperatively if possible. In this, several kinds of roentgen studies are helpful. Infusions of drugs during operation can be used to control the blood pressure which otherwise would vary widely. During a ten-year period (1942 to 1951) there were observed at the Los Angeles County General Hospital 100 proved cases of non-secreting and secreting primary neoplasms of the adrenal glands. In addition, there were three cases of Cushing's syndrome due to bilateral adrenal cortical hyperplasia, and ten probable cases (four, pheochromocytomas; five, Cushing's syndrome; one, adrenogenital syndrome) in which operation was not done.

Entities:  

Keywords:  ADRENAL GLANDS/neoplasms

Mesh:

Year:  1952        PMID: 13009500      PMCID: PMC1521546     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  2 in total

1.  Untoward reactions to tests for epinephrine-secreting tumors (pheochromocytoma).

Authors:  H R BIERMAN; J W PARTRIDGE
Journal:  N Engl J Med       Date:  1951-04-19       Impact factor: 91.245

2.  Diagnosis of pheochromocytoma by the adrenergic blocking action of benzodioxan.

Authors:  M GOLDENBERG; H ARANOW
Journal:  J Am Med Assoc       Date:  1950-07-29
  2 in total
  1 in total

1.  Large abdominal tumors of childhood; other than Wilms' tumor or neuroblastoma.

Authors:  C M LEE; J R NEWSTEDT; H S SIDDALL
Journal:  Ann Surg       Date:  1956-06       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.